Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 9 |
| Unknown status | 9 |
| Terminated | 5 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 11 |
| Seoul National University Hospital | 4 |
| Amgen | 3 |
| Bristol-Myers Squibb | 3 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| AbbVie | 1 |
| Accenture | 1 |
| Ajou University School of Medicine | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 46 |
| Leukemia, Myeloid, Acute | 11 |
| Leukemia, Myeloid, Accelerated Phase | 6 |
| Multiple Myeloma | 6 |
| Myelodysplastic Syndromes | 6 |
| Blast Crisis | 5 |
| Leukemia | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Leukemia, Myeloid, Chronic-Phase | 5 |
| Leukemia, Myelomonocytic, Chronic | 5 |
Trials
Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.